1

2

Ø The National pharmaceuticals factory was established in 2014 at the SecondIndustrial City in Riyadh.

Ø With surface area of 9000 square meters, designed and equipped to the highestspecifications in accordance with the SFDA requirement.

The factory has the following product lines:

Ø Liquids line - disinfectants and antiseptics, lotions, liquid soaps, Hand gels andmouth wash.

Ø Semi solids line - creams, ointments, gels.

Ø Obtained a license from the SFDA to manufacture and pack cosmetics, Health andHerbal pharmaceuticals products on May 2015.

Ø Future product pipeline – Tablets, Capsules, Oral Liquids and Conventionalpackaging lines.

WHO WE ARE

Focused on customer service

satisfaction

Financially and

Dynamically growing

Registered capital of

20,000,000 SAR

($5,332,000USD)

Professional team with

competency

Rich pipeline of

innovative product

Committed to produce high quality products as per cGMP and SFDA

Objective

4

Ø Provide the best methods of global

pharmaceutical Industry standards.

Ø Localization and transfer of Technology

Ø Highest quality requirements in the

pharmaceutical industries.

5

Our success lies in meeting the needs of our

customers earn their trust and their

satisfaction with the Permanent focus on the

evolution and adaptation to changing needs as well

as maintaining the quality of products which opens

the way for us, because we are the region's leading

pharmaceutical companies.

Attract global companies of medicine, health

and pharmaceuticals alliances and to work to

conclude contracts for the manufacture or

Packaging products of these companies.

Vision

6

MILESTONES

7

By End of 2019 NPF will

have 72products

End of 2018 NPF has 54products

End of 2017 NPF has 48 products

End of 2016 NPF has

24 products

In 2015 NPF was

producing 2 products

8

Quality System

Quality Assurance

Quality Management

System

Audits

SOP System

GMP

GLP

Change Control

Training

Regulatory Compliance

Our current clients in Kingdom

NPF Sales Vision

Our vision “ To become a leading Pharmaceutical company in the GCC and Global region”